Sania Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $5M

  • Investors
  • 7

Sania Therapeutics General Information

Description

Developer of gene therapies intended to improve the quality of life of people with neurological diseases. The company uses virology, molecular biology, and bioinformatics to build therapies that are precisely targeted to neural circuits by delivering genetic material to infected cells, enabling healthcare providers to cure neurological disorders effectively.

Contact Information

Website
www.saniarx.com
Formerly Known As
Sania Rx, ARR1
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Waterfront building
  • Manbre Road
  • London W6 9RH
  • England, United Kingdom
+44 07354
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Waterfront building
  • Manbre Road
  • London W6 9RH
  • England, United Kingdom
+44 07354

Sania Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sania Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 06-May-2024 $5M Completed Generating Revenue
4. Accelerator/Incubator 01-May-2024 Completed Generating Revenue
3. Seed Round 01-Mar-2023 Completed Pre-Clinical Trials
2. Seed Round 18-Mar-2022 $5.05M $5.05M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2021 Completed Startup
To view Sania Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sania Therapeutics Patents

Sania Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202502500-D0 Method Inactive 20-Feb-2025
GB-202416499-D0 Method Pending 08-Nov-2024
GB-202416503-D0 Method Pending 08-Nov-2024
GB-202416507-D0 Method Pending 08-Nov-2024
GB-202406331-D0 Capsid Inactive 07-May-2024 C07K14/005
To view Sania Therapeutics’s complete patent history, request access »

Sania Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sania Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Harbrook Corporation Minority
SCI Ventures (London) Venture Capital Minority
Grow London Accelerator/Incubator
Arc Ventures (United States) Venture Capital Minority
Axial (San Francisco) Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Sania Therapeutics FAQs

  • When was Sania Therapeutics founded?

    Sania Therapeutics was founded in 2021.

  • Where is Sania Therapeutics headquartered?

    Sania Therapeutics is headquartered in London, United Kingdom.

  • What is the size of Sania Therapeutics?

    Sania Therapeutics has 15 total employees.

  • What industry is Sania Therapeutics in?

    Sania Therapeutics’s primary industry is Drug Discovery.

  • Is Sania Therapeutics a private or public company?

    Sania Therapeutics is a Private company.

  • What is Sania Therapeutics’s current revenue?

    The current revenue for Sania Therapeutics is .

  • How much funding has Sania Therapeutics raised over time?

    Sania Therapeutics has raised $11.5M.

  • Who are Sania Therapeutics’s investors?

    Harbrook, SCI Ventures (London), Grow London, Arc Ventures (United States), and Axial (San Francisco) are 5 of 7 investors who have invested in Sania Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process